Dis-Chem: my pick in the sector

Dis-Chem has several growth levers and seems to be pulling all of them, delivering a strong result in FY22.

Clicks is struggling in wholesale

The Clicks share price is flat this year, so it's been a much better investment than the US tech companies that the market got too excited about in 2021

Netcare is the perfect example of operating leverage

In a voluntary trading update for the six months to March 2022, Netcare announced that it achieved revenue growth of between 2% and 2.5%.

Mediclinic doing well in the recovery room

Mediclinic has provided a trading update for the year ended March 2022. With full results scheduled for release on 25 May, this gives the market a taste of what happened in that period

Life’s EBITDA margin is a mixed bag

Life Healthcare has released a voluntary trading update for the six months to March 2022. This covers the first half of the 2022 financial year.

Ascendis: more info on the businesses for sale

Ascendis Health has given further information on the financial information of the businesses that form part of the proposed disposal plan.